top of page
Jul 313 min read
Resmetirom: The Game-Changer in MASH and MASLD Management
More details about MASH and MASLD can be found in the previous article, Everybody’s gotta live(r). In that article, we mentioned that at...
Jun 175 min read
Magic Mushrooms for Depression?
Understanding the FDA's Breakthrough Therapy Designation for CYB003 The News: The FDA granted Breakthrough Therapy Designation (BTD) – a...
Mar 236 min read
Decoding Arterial Stiffness: A Conversation with Dr. Bart Spronck
Explore the complexities of arterial stiffness with Dr. Bart Spronck, a researcher at Maastricht University. In this interview, Dr....
Feb 196 min read
Unlocking the Enigma of Ketamine: Insights from a Neuroscientist's Perspective
In a previous article, we explored the enantiomers of ketamine, an enigmatic compound that has held scientists’ attention in the field of...
Nov 24, 20237 min read
Flex or Fail: Decoding the Language of Arterial Stiffness
Our cardiovascular system is a complex network of vessels, carrying life-sustaining blood throughout our bodies. The health of our...
Oct 14, 20235 min read
Shining a Light on Tumor Microenvironment: The Role of Theranostics
We had the privilege of interviewing Dr. Filipe Elvas, an assistant research professor from the Center for Radiopharmaceuticals Antwerp...
Jul 30, 20235 min read
Radio-Theranostics: Uniting Diagnosis and Treatment, the Ultimate Medical Matchmaker
'See what you treat and treat what you see, at a molecular level' (Cit. Heying Duan) What is Theranostic and Radio-Theranostic?...
Jun 15, 202310 min read
Ketamine: From Surgery to Antidepressant Salvation?
History and current pharmacological applications of Ketamine: from an analgesic to an anti-depressive drug
Mar 11, 202311 min read
Interview with Prof Dr Sven Francque
Last year we interviewed Prof Dr Sven Francque one of the leading researchers worldwide in the field of NAFLD and NASH. The FDA recently...
Mar 10, 20238 min read
Everybody’s gotta live(r)
A summary of the current situation regarding non-alcoholic fatty liver disease (NAFLD), followed by an interview with Prof. Dr Sven...
bottom of page